[Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
Recently "K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease" was published. It consists of sixteen precise guidelines which cover the wide range of this field. It is expected that these guidelines contribute ESRD treatment in Japan in spite of some differences in medical practice for dialysis therapy between Japan and the United States. This article briefly summarizes the outlines of these guidelines.
Orita
Hikari
H
Center of Blood Purification Therapy, Wakayama Medical University.
Akizawa
Tadao
T
D015502:Absorptiometry, Photon; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D002136:Calcium, Dietary / Q000008:administration & dosage; D002908:Chronic Disease; D004852:Epoxy Compounds / Q000627:therapeutic use; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007564:Japan; D007674:Kidney Diseases / Q000150:complications*; D016105:Parathyroidectomy; D016226:Phosphorus, Dietary / Q000008:administration & dosage; D011073:Polyamines; D011095:Polyethylenes / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D000069603:Sevelamer; D014481:United States; D014807:Vitamin D / Q000008:administration & dosage; D014808:Vitamin D Deficiency / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D002136:Calcium, Dietary; D004852:Epoxy Compounds; D016226:Phosphorus, Dietary; D011073:Polyamines; D011095:Polyethylenes; D014807:Vitamin D; D000069603:Sevelamer